Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MAT2A | P31153 | 1/20 | 0.32 |
| ▸ | SCN10A | Q9Y5Y9 | 2/20 | 0.31 |
| ▸ | CNR2 | P34972 | 1/20 | 0.30 |
| ▸ | STK4 | Q13043 | 1/20 | 0.30 |
| ▸ | STK3 | Q13188 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30538962 | 0.92 | MAT2A (0.35) | ALDH1A1SMN1; SMN2MAT2ASCN10ACNR2 | |
| SCHEMBL27152461 | 0.92 | MAT2A (0.35) | ALDH1A1SMN1; SMN2MAT2ASCN10ACNR2 | |
| SCHEMBL27066611 | 0.92 | MAT2A (0.35) | ALDH1A1SMN1; SMN2MAT2ASCN10ACNR2 | |
| SCHEMBL31470321 | 0.85 | RORC (0.33) | ALDH1A1SMN1; SMN2CNR2 | |
| SCHEMBL27147161 | 0.84 | SMN1; SMN2 (0.44) | ALDH1A1SMN1; SMN2MAT2A | |
| SCHEMBL17030874 | 0.84 | SMN1; SMN2 (0.44) | ALDH1A1SMN1; SMN2MAT2A | |
| SCHEMBL27136960 | 0.83 | MAT2A (0.35) | MAT2ASCN10ACNR2 | |
| SCHEMBL27136962 | 0.83 | MAT2A (0.35) | MAT2ASCN10ACNR2 | |
| SCHEMBL25165368 | 0.83 | MAT2A (0.35) | ALDH1A1SMN1; SMN2MAT2ASCN10ACNR2 | |
| SCHEMBL25235889 | 0.83 | MAT2A (0.35) | ALDH1A1SMN1; SMN2MAT2ASCN10ACNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025077770-A1 | FUSED RING COMPOUND AND USE THEREOF IN KRAS INHIBITOR | 成都海博为药业有限公司 | 2025-04-17 | — | — | WO | disclosed |